C
Codexis, Inc. (CDXS)
NMS – Real vaqt narxi. Valyuta: USD
2.54
-0.11 (-4.15%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
2.54
-0.11 (-4.15%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Codexis, Inc. AQSh, Kanada, Lotin Amerikasi, Yevropa, Yaqin Sharq, Afrika, Avstraliya, Yangi Zelandiya, Janubi-Sharqiy Osiyo va Xitoyda o'ziga xos CodeEvolver texnologiya platformasidan foydalanib, yangi fermentlarni kashf qilish, ishlab chiqish, takomillashtirish va tijoratlashtirish uchun terapevtik vositalar ishlab chiqarish bo'yicha texnologik yechimlarni taqdim etadi. Kompaniya fermentativ yo'l orqali RNAi terapevtik vositalarini keng miqyosda ishlab chiqarishni ta'minlash uchun o'ziga xos ECO Synthesis ishlab chiqarish platformasini ishlab chiqadi. U Aldevron LLC va Pfizer Inc. bilan litsenziya shartnomasiga ega. Kompaniya 2002 yilda tashkil etilgan va shtab-kvartirasi Kaliforniyaning Redwood City shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Alison Moore Ph.D. | President, CEO & Director |
| Dr. Stefan Lutz Ph.D. | Chief Scientific Officer |
| Mr. Britton Jimenez | Senior Vice President of Sales & Marketing |
| Mr. John Schiffhauer | Senior Vice President of Intellectual Property |
| Ms. Georgia L. Erbez | CFO & Chief Business Officer |
| Ms. Karen Frechou-Armijo | Senior VP & Head of Human Resources |
| Senator Byron L. Dorgan M.B.A. | Consultant |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | d112205d8k.htm |
| 2026-04-28 | DEFA14A | d16434ddefa14a.htm |
| 2026-04-28 | DEF 14A | d939868ddef14a.htm |
| 2026-04-14 | 8-K | d96482d8k.htm |
| 2026-03-11 | 10-K | cdxs-20251231.htm |
| 2025-11-06 | 8-K | d80118d8k.htm |
| 2025-11-06 | 10-Q | cdxs-20250930.htm |
| 2025-08-13 | 8-K | d940510d8k.htm |
| 2025-08-13 | 10-Q | cdxs-20250630.htm |
| 2025-06-11 | 8-K | d41532d8k.htm |